Literature DB >> 25061123

A slight increase within the normal range of serum uric acid and the decline in renal function: associations in a community-based population.

Keita Kamei1, Tsuneo Konta2, Atsushi Hirayama1, Kazuko Suzuki1, Kazunobu Ichikawa1, Shouichi Fujimoto3, Kunitoshi Iseki3, Toshiki Moriyama3, Kunihiro Yamagata3, Kazuhiko Tsuruya3, Kenjiro Kimura3, Ichiei Narita3, Masahide Kondo3, Koichi Asahi3, Tsuyoshi Watanabe3.   

Abstract

BACKGROUND: Hyperuricemia is a risk factor for adverse renal outcomes in patients with chronic kidney disease. This study investigated the effect of uric acid on renal function in a community-based population.
METHODS: We used a nationwide database of 165 847 subjects (aged 29-74, male 40%) who participated in the annual 'Specific Health Check and Guidance in Japan' checkup between 2008 and 2010; we examined the relationship between serum uric acid levels at baseline and 2-year change in the estimated glomerular filtration rate (eGFR) obtained by using the Japanese equation.
RESULTS: After adjusting for possible confounders, the eGFR change was inversely correlated with uric acid at baseline. In the multivariable analysis, the decline in eGFR was significantly more rapid in subjects with the slight increase in uric acid (males ≥5.7 mg/dL, females ≥4.4 mg/dL), and the risk for incidental renal insufficiency (eGFR <60 mL/min/1.73 m(2)) was increased at uric acid of ≥6.3 mg/dL in males and ≥5.5 mg/dL in females, compared with the lowest quintile. The multiple linear regression analysis revealed that the effect of uric acid on eGFR changes was significant, especially in females, those with proteinuria and diabetes and those without alcohol consumption.
CONCLUSION: This study showed that serum uric acid is independently associated with a more rapid decline of eGFR and incident renal insufficiency, and that a slight increase within the normal range of serum uric acid might be a risk for renal damage in the general population.
© The Author 2014. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  cohort study; renal function; uric acid

Mesh:

Substances:

Year:  2014        PMID: 25061123     DOI: 10.1093/ndt/gfu256

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  21 in total

1.  Associations between serum uric acid levels and the incidence of nonfatal stroke: a nationwide community-based cohort study.

Authors:  Keita Kamei; Tsuneo Konta; Atsushi Hirayama; Kazunobu Ichikawa; Isao Kubota; Shouichi Fujimoto; Kunitoshi Iseki; Toshiki Moriyama; Kunihiro Yamagata; Kazuhiko Tsuruya; Ichiei Narita; Masahide Kondo; Yugo Shibagaki; Masato Kasahara; Koichi Asahi; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2016-07-12       Impact factor: 2.801

2.  Effects of topiroxostat in hyperuricemic patients with chronic kidney disease.

Authors:  Taro Horino; Yutaka Hatakeyama; Osamu Ichii; Tatsuki Matsumoto; Yoshiko Shimamura; Kosuke Inoue; Yoshio Terada; Yoshiyasu Okuhara
Journal:  Clin Exp Nephrol       Date:  2017-07-27       Impact factor: 2.801

3.  The association between genotypes of urate transporter-1, Serum uric acid, and mortality in the community-based population: the Yamagata (Takahata) Study.

Authors:  Soichiro Kon; Tsuneo Konta; Kazunobu Ichikawa; Masafumi Watanabe; Hidenori Sato; Kenichi Ishizawa; Yoshiyuki Ueno; Hidetoshi Yamashita; Takamasa Kayama
Journal:  Clin Exp Nephrol       Date:  2019-09-03       Impact factor: 2.801

Review 4.  The role of uric acid in mineral bone disorders in chronic kidney disease.

Authors:  Baris Afsar; Alan A Sag; Cinar Oztosun; Masanari Kuwabara; Mario Cozzolino; Adrian Covic; Mehmet Kanbay
Journal:  J Nephrol       Date:  2019-04-27       Impact factor: 3.902

5.  Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial.

Authors:  Kenichi Tanaka; Masaaki Nakayama; Makoto Kanno; Hiroshi Kimura; Kimio Watanabe; Yoshihiro Tani; Yoshimitsu Hayashi; Koichi Asahi; Hiroyuki Terawaki; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2015-02-13       Impact factor: 2.801

6.  Urinary polycyclic aromatic hydrocarbons and measures of oxidative stress, inflammation and renal function in adolescents: NHANES 2003-2008.

Authors:  Shohreh F Farzan; Yu Chen; Howard Trachtman; Leonardo Trasande
Journal:  Environ Res       Date:  2015-11-21       Impact factor: 6.498

7.  Genetic and environmental influences on the associations between change in kidney function and changes in cardiometabolic factors in Koreans.

Authors:  Yun-Mi Song; Joohon Sung; Kayoung Lee
Journal:  Clin Exp Nephrol       Date:  2016-06-23       Impact factor: 2.801

8.  Urate crystal deposition, prevention and various diagnosis techniques of GOUT arthritis disease: a comprehensive review.

Authors:  Panchatcharam Parthasarathy; S Vivekanandan
Journal:  Health Inf Sci Syst       Date:  2018-10-08

Review 9.  Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease.

Authors:  Hitoshi Nishizawa; Norikazu Maeda; Iichiro Shimomura
Journal:  Hypertens Res       Date:  2022-01-19       Impact factor: 3.872

10.  Association between polymorphism at IGF-1 rs35767 gene locus and long-term decline in renal function: a Japanese retrospective longitudinal cohort study.

Authors:  Kosuke Honda; Satoru Kuriyama; Kimiyoshi Ichida; Tomoko Nakano; Naoki Sugano; Takashi Yokoo
Journal:  BMC Nephrol       Date:  2021-06-02       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.